The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

DLA Piper LLP (US)

Work +1 215 656 3300
Fax +1 215 656 3301

Raymond Williams

Work +1 215 656 3368
DLA Piper LLP (US)

Work Department

Litigation, Arbitration and Investigations; Product Liability, Mass Torts and Product Stewardship; Life Sciences; Healthcare


Partner, National Diversity and Inclusion Partner


Raymond Williams focuses his practice on complex litigation and is a partner in the firm's Philadelphia office. Mr. Williams is the firm's national Diversity and Inclusion Partner. In 2006, Mr. Williams was selected as the first-chair of the Defense Research Institute's Diversity & Inclusion Committee. Mr. Williams is the immediate past president of the Philadelphia Diversity Law Group.

Mr. Williams has first-chair jury trial experience, as well as extensive pre-trial litigation experience. He has used these skills to work on pro bono matters supported by his firm. Currently, Mr. Williams is engaged in a matter questioning the documentation requirements needed by legal permanent residents to vote in local elections. Most recently he successfully represented the Navajo Human Rights Commission and other Navajo plaintiffs regarding their unequal access to voting polls in San Juan, Utah.

Mr. Williams is a frequent speaker and contributor to litigation journals and industry publications regarding both diversity issues and his substantive practice area. On numerous occasions Mr. Williams has appeared as a panelist on the Law Journal TV program and the American Law Journal TV program.


J.D., Pepperdine University School of Law; B.S., University of Rhode Island

United States: Dispute resolution

Product liability, mass tort and class actions: pharmaceuticals and medical devices - defense

Within: Product liability, mass tort and class actions: pharmaceuticals and medical devices - defense

DLA Piper LLP (US) is headed by Raymond Williams in Philadelphia and Christopher Young in San Diego, and is one of the leading firms for high-profile product liability litigation and mass torts in the medical and pharmaceuticals sectors. Notable highlights include representing Medtronic and Covidien as co-national counsel in the hernia mesh litigation, and defending Pfizer and Wyeth Pharmaceuticals in product liability litigation, in which plaintiffs claim that long-term use of proton pump inhibitors (PPIs) cause various forms of kidney disease. In other work, the highly regarded Loren Brown in New York is acting for Pfizer alongside Boston-based Matthew Holian in an MDL involving claims that anti-coagulant medication Eliquis causes bleeding. Cara Edwards in New York is also recommended. In January 2018, the team welcomed Stephen Matthews and Amy Rubenstein from Porzio, Bromberg & Newman and Schiff Hardin LLP respectively; in February 2018, Matt Nickel and Mike Moore joined from Dentons.

[back to top]

Back to index

Legal Developments by:
DLA Piper LLP (US)

  • Sentencing guidelines for corporate manslaughter

    In February 2010 the Sentencing Guidelines Council (the SGC) issued definitive guidelines to courts on imposing appropriate sentences for corporate manslaughter and health and safety offences causing death. The SGC states that fines imposed on companies found guilty of corporate manslaughter should not fall below £500,000, while fines in respect of health and safety offences that are a significant cause of death should be at least £100,000. Crucially, the SGC declined to provide for a fixed link between the imposed fine and the turnover or profitability of the offending company.

    - DLA Piper UK LLP

Legal Developments worldwide

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to